The economic burden of bipolar I disorder in the United States in 2015

Journal of Affective Disorders

Volumn 226, Issue , 2018, Pages 45-51

  Cloutier, Martin ^a   Greene, Mallik ^c   Guerin, Annie ^a   Touya, Maelys ^d   Wu, Eric ^b  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^c LUNDBECK RESEARCH USA   (United States)

^d ANALYSIS GROUP   (United States)

Author keywords

Bipolar disorder; Economic burden; Healthcare costs; Indirect costs

Indexed keywords

ADULT; ARTICLE; BIPOLAR I DISORDER; COST OF ILLNESS; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICALLY UNINSURED; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; UNEMPLOYMENT; UNITED STATES; AGED; BIPOLAR DISORDER; ECONOMICS; EPIDEMIOLOGY; MIDDLE AGED; PREVALENCE; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; BIPOLAR DISORDER; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; UNITED STATES;

EID: 85029781681     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2017.09.011     Document Type: Article

References (51)

1. American Diabetes Association, 2013. The Cost of Diabetes 2013. 〈 http://www.diabetes.org/advocacy/news-events/cost-of-diabetes.html〉 (Accessed 27 February 2017).
2. American Psychiatric Association, 1980. Diagnostic and Statistical Manual of Mental Disorders: Third Edition. 〈http://dsm.psychiatryonline.org/doi/pdf/10.1176/appi.books.9780521315289.dsm-iii〉 (Accessed 27 March 2017).
3. American Psychiatric Association, 2013. Diagnostic and Statistical Manual of Mental Disorders: Fifth Edition. 〈http://dsm.psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596〉 (Accessed 27 March 2017).
4. Anderson, I.M., Haddad, P.M., Scott, J., Bipolar disorder. BMJ: Br. Med. J., 345, 2012, e8508.
5. Begley, C.E., Annegers, J.F., Swann, A.C., Lewis, C., Coan, S., Schnapp, W.B., Bryant-Comstock, L., The lifetime cost of bipolar disorder in the US. Pharmacoeconomics 19 (2001), 483–495.
6. Belmaker, R.J., Bipolar disorder. N. Engl. J. Med. 351 (2004), 476–486.
7. Bouchery, E.E., Harwood, H.J., Sacks, J.J., Simon, C.J., Brewer, R.D., Economic costs of excessive alcohol consumption in the U.S., 2006. Am. J. Prev. Med. 41 (2011), 516–524.
8. Carney, C.P., Jones, L.E., Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom. Med. 68 (2006), 684–691.
9. Cassidy, F., Ahearn, E., Carroll, B., Substance abuse in bipolar disorder. Bipolar Disord. 3 (2001), 181–188.
10. Cloutier, M., Aigbogun, M.S., Guerin, A., Nitulescu, R., Ramanakumar, A.V., Kamat, S.A., DeLucia, M., Duffy, R., Legacy, S.N., Henderson, C., Francois, C., Wu, E., The economic burden of schizophrenia in the United States in 2013. J. Clin. Psychiatry 77 (2016), 764–771.
11. Collins, D.J., Lapsley, H.M., 2008. The costs of tobacco, alcohol and illicit drug abuse to Australian society in 2004/05. 〈 http://tobacco.cleartheair.org.hk/wp-content/uploads/2012/06/mono64.pdf〉 (Accessed 27 March 2017).
12. Coughlin, T.A., Holahan, J., Caswell, K., McGrath, M., 2014. Uncompensated Care for Uninsured in 2013: A Detailed Examination. The Kaiser commission on Medicaid and the Unisured. 〈 http://kff.org/uninsured/report/uncompensated-care-for-the-uninsured-in-2013-a-detailed-examination/〉 (Accessed 27 March 2017).
13. Crump, C., Sundquist, K., Winkleby, M.A., Sundquist, J., Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry 70 (2013), 931–939.
14. Dilsaver, S.C., An estimate of the minimum economic burden of bipolar I and II disorders in the United States: 2009. J. Affect. Disord. 129 (2011), 79–83.
15. Escamilla, M.A., Zavala, J.M., Genetics of bipolar disorder. Dialogues Clin. Neurosci. 10 (2008), 141–152.
16. Gianfrancesco, F.D., Wang, R.H., Yu, E., Effects of patients with bipolar, schizophrenic, and major depressive disorders on the mental and other healthcare expenses of family members. Soc. Sci. Med. 61 (2005), 305–311.
17. Gitlin, M., Frye, M.A., Maintenance therapies in bipolar disorders. Bipolar Disord. 14:Suppl 2 (2012), S51–S65.
18. Greenberg, P.E., Fournier, A.A., Sisitsky, T., Pike, C.T., Kessler, R.C., The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J. Clin. Psychiatry 76 (2015), 155–162.
19. Harrison, P.J., Cipriani, A., Harmer, C.J., Nobre, A.C., Saunders, K., Goodwin, G.M., Geddes, J.R., Innovative approaches to bipolar disorder and its treatment. Ann. N. Y. Acad. Sci. 1366 (2016), 76–89.
20. Hawke, L.D., Parikh, S.V., Michalak, E.E., Stigma and bipolar disorder: a review of the literature. J. Affect. Disord. 150 (2013), 181–191.
21. IsHak, W.W., Brown, K., Aye, S.S., Kahloon, M., Mobaraki, S., Hanna, R., Health-related quality of life in bipolar disorder. Bipolar Disord. 14 (2012), 6–18.
22. Jann, M., Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments. Am. Health Drug Benefits 7 (2014), 489–499.
23. Janssen, Caregiving and Schizophrenia, 2012 〈http://www.schizophrenia.ca/docs/CARE%20Survey%20News%20Release%20Final%20at%20October%2012%202012.pdf〉 (Accessed 27 March 2017).
24. Kessler, R., Berglund, P., Demler, O., Jin, R., Merikangas, K., Walters, E., Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62 (2005), 593–602.
25. Kessler, R., Chiu, W., Demler, O., Merikangas, K., Walters, E., Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62 (2005), 617–627.
26. Kleinman, L., Lowin, A., Flood, E., Gandhi, G., Edgell, E., Revicki, D., Costs of bipolar disorder. Pharmacoeconomics 21 (2003), 601–622.
27. Kleinman, N.L., Brook, R.A., Rajagopalan, K., Gardner, H.H., Brizee, T.J., Smeeding, J.E., Lost time, absence costs, and reduced productivity output for employees with Bipolar Disorder. J. Occup. Environ. Med. 47 (2005), 1117–1124.
28. Kochanek, K., Murphy, S., Xu, J., Tejada-Vera, B., Deaths: Final Data for 2014. US Department of Health Human. Serv., 2016 〈https://www.cdc.gov/nchs/data/nvsr/nvsr65/nvsr65_04.pdf〉 (Accessed 27 March 2017).
29. Kupfer, D.J., Frank, E., Grochocinski, V.J., Cluss, P.A., Houck, P.R., Stapf, D.A., Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J. Clin. Psychiatry 63 (2002), 120–125.
30. McGinty, E.E., Busch, S.H., Stuart, E.A., Huskamp, H.A., Gibson, T.B., Goldman, H.H., Barry, C.L., Federal parity law associated with increased probability of using out-of-network substance use disorder treatment services. Health Aff. (Proj. Hope) 34 (2015), 1331–1339.
31. Menke, A., Casagrande, S., Geiss, L., Cowie, C.C., Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA 314 (2015), 1021–1029.
32. Merikangas, K.R., Akiskal, H.S., Angst, J., Greenberg, P.E., Hirschfeld, R., Petukhova, M., Kessler, R.C., Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Arch. Gen. Psychiatry 64 (2007), 543–552.
33. Merikangas, K.R., Akiskal, H.S., Angst, J., Greenberg, P.E., Hirschfeld, R.M., Petukhova, M., Kessler, R.C., Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch. Gen. Psychiatry 64 (2007), 543–552.
34. Merikangas, K.R., Jin, R., He, J.-P., Kessler, R.C., Lee, S., Sampson, N.A., Viana, M.C., Andrade, L.H., Hu, C., Karam, E.G., Ladea, M., Mora, M.E.M., Browne, M.O., Ono, Y., Posada-Villa, J., Sagar, R., Zarkov, Z., Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch. Gen. Psychiatry 68 (2011), 241–251.
35. Michalak, E.E., Yatham, L.N., Maxwell, V., Hale, S., Lam, R.W., The impact of bipolar disorder upon work functioning: a qualitative analysis. Bipolar Disord. 9 (2007), 126–143.
36. Munnell, A.H., 2015. The Average Retirement Age – An Update. Center for Retirement Research at Boston College. 〈 http://crr.bc.edu/wp-content/uploads/2015/03/IB_15-4_508_rev.pdf〉 (Accessed 27 March2017).
37. National Alliance for Caregiving, 2016. On pins and needles: caregivers of adults with mental illness. 〈 http://www.caregiving.org/wp-content/uploads/2016/02/NAC_Mental_Illness_Study_2016_FINAL_WEB.pdf〉 (Accessed 27 March 2017).
38. National Alliance for Caregiving, 2015. Caregiving in the US. 〈 http://www.caregiving.org/caregiving2015/〉 (Accessed 27 March 2017).
39. National Institute of Mental Health, 2016. Bipolar Disorder. 〈 https://www.nimh.nih.gov/health/topics/bipolar-disorder/index.shtml〉 (Accessed 27 March 2017).
40. Obama, B., United States health care reform: progress to Date and next steps. JAMA 316 (2016), 525–532.
41. Park, C.Y., Murphy, L.J., Bruen, B.K., McCune, J.M., 2008. Trends in Medicare Part D Coverage of Chronic Condition Medications 〈 http://avalere.com/research/docs/MAPRx_Chronic_Conditions.pdf〉 (Accessed 27 March 2017).
42. US Bureau of Labor Statistics, 2015. Usual weekly earnings of wage and salary workers, first quarter 2015 〈 https://www.bls.gov/news.release/archives/wkyeng_04212015.htm〉 (Accessed 27 March 2017).
43. US Bureau of Labor Statistics, 2017a. Consumer Price Index - All Urban Consumers 〈 https://data.bls.gov/cgi-bin/surveymost?cu〉 (Accessed 27 January 2017).
44. US Bureau of Labor Statistics, 2017b. United States Bureau of Labor Statistics 〈 https://www.bls.gov/home.htm〉 (Accessed 17 January 2017).
45. US Census Bureau, 2015. United States Census Bureau. 〈 https://www.census.gov/〉 (Accessed 17 January 2017).
46. US Department of Health and Human Services National Institute of Health, 2016. Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC). 〈 https://report.nih.gov/categorical_spending.aspx〉 (Accessed 23 December 2016).
47. US Department of Justice, 2011. The economic impact of illicit drug use on american society. 〈 https://www.justice.gov/archive/ndic/pubs44/44731/44731p.pdf〉 (Accessed 27 March 2017).
48. US Department of Labor, 2010. The Mental Health Parity and Addiction Equity Act of 2008. 〈 https://www.dol.gov/sites/default/files/ebsa/about-ebsa/our-activities/resource-center/fact-sheets/fsmhpaea.pdf〉 (Accessed 27 March2017).
49. Westman, J., Hallgren, J., Wahlbeck, K., Erlinge, D., Alfredsson, L., Osby, U., Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden. BMJ Open, 3, 2013, e002373.
50. Wu, E.Q., Birnbaum, H.G., Shi, L., Ball, D.E., Kessler, R.C., Moulis, M., Aggarwal, J., The economic burden of schizophrenia in the United States in 2002. J. Clin. Psychiatry 66 (2005), 1122–1129.
51. Wyatt, R.J., Henter, I., An economic evaluation of manic-depressive illness–1991. Soc. Psychiatry Psychiatr. Epidemiol. 30 (1995), 213–219.